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I – RECOMMENDED SET OF SAMPLES:
► Number of samples: the risk of not detecting an anomaly is directly determined by
the number of samples included in the set. The table shows the risk interval according to
the number of samples in the set (confidence interval of 95 %):
A compromise must be found between a lower risk and a reasonable number of 
samples: our suggestion would be 20-25 samples.
► Sample status : since it is impossible to assess the specificity of a participant using a 
low number of negative samples, we recommend to include more positive and positive 
limits in the set. Only few negative samples are to be included. 
► Codification: the samples should be randomly codified.
► Volume : The volume of samples should be limited to three repetition of the test.
Summary:
Theme 4 of EPIZONE is dedicated to the development and standardisation of the diagnostic tools for epizootic diseases. To achieve this objective, regular ring trials are organised within the
network. However, to our knowledge, they are designed and organised by different laboratories with no established standards. In agreement with a recent report on the Euroepan network of
excellence (1), we believe that EPIZONE could somehow play a role in improving quality, particularly in the present case, for the standardisation of ring trials designed for the comparison and
validation of diagnostic methods. As a starting point, we decided to review three European ring trials into which we took part (AIV/RRT-PCR, BT/ELISA & PCR(2), ASF/ELISA & PCR), one that
we are currently organising for EPIZONE (PPR/ELISA & PCR) and three others that we have organised in 2008 either at the international, European or national level (AIV/RRT-PCR,
Culicoides/PCR, BT/ELISA). From this evaluation, it is possible to make suggestions for harmonisation. EPIZONE could promote the definition of guidelines for the organisation of such ring
trials, taking into account the international standards available (3, 4).
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II- CRITERIA TO INCLUDE:
According to the OIE and ISO guidelines for Laboratory Proficiency Testing (3, 4), the 
criteria to be assessed should be:
► Sensitivity: capacity to detect a true positive sample.
► Specificity: capacity to score as negative, a true negative sample. 
► Detectability: capacity to detect a minimum quantity of the target
► Dose/Effect response: for quantitative results only, capacity to generate a linear curve 
for serial dilutions.
► Repeatability: capacity to generate identical results on repetitions of the same sample.
PROPOSITIONS
Standardisation of the ring trials within EPIZONE could be based of a recommended set of samples, a list of criteria to be evaluated and a template for the final result reporting. 
III- REPORTING
The final report should include an overall analysis of the ring trial with an 
anonymous result reporting and a statement on conforming and non conforming 
results to individual laboratory participant.
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Number of 
samples 
Number of results 
corresponding 
 to the expected results 
Risk of not detecting 
an anomaly 
5 5 0 % à 45 % 
10 10 0 % à 25 % 
28 28 0 % à 10 % 
60 60 0 % à  5 % 
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